Author:
Scatchard K.,Rohatiner A. Z. S.,Slater S.,Paralles M. Camball,Davis C.,Amess J.,Lister T. A.
Publisher
Springer Berlin Heidelberg
Reference7 articles.
1. Rohatiner A, Bassan R, Battista R, al e: Myeloablative therapy with autologous bone marrow transplantation (ABMT) as consolidation of first remission in younger patients with acute myelogenous leukaemia (AML). Blood 10(Suppl 1):753, 1993.
2. Rohatiner A, Bassan R, Bjorkholm M, al e: High-dose treatment with peripheral blood progenitor cell support as consolidation of first remission in younger patients with acute myelogenous leukaemia. Blood 92(Suppl 1):293a, 1998.
3. Slevin ML, Rohatiner AZ, Dhaliwal HS, Henry GP, Bell R, Lister TA: A comparison of two schedules of Cytosine Arabinoside used in combination with Adriamycin and 6-Thioguanine in the treatment of acute myelogenous leukaemia. Medical and Paediatric Oncology Supplement 1:185, 1982.
4. Rohatiner AZ, Slevin ML, Dhaliwal HS, Malpas JS, Lister TA: High dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkins lymphoma. Cancer Chemotherapy and Pharmacology 12:90, 1984.
5. Rohatiner AZ, Gregory WM, Bassan R, Barnett MJ, Waxman J, Richards MA, Ganesan TS, Tucker J, Malik STA, Biruls R, Amess J, Berney S, Malpas JS, Lister TA: Short-term Therapy for Acute Myelogenous Leukaemia. Journal of Clinical Oncology 6(2):218, 1988.